These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12818418)

  • 41. Antibodies to oxidized low-density lipoproteins and angiographically assessed coronary artery disease in white patients.
    Rossi GP; Cesari M; De Toni R; Zanchetta M; Maiolino G; Pedon L; Ganzaroli C; Maiolino P; Pessina AC
    Circulation; 2003 Nov; 108(20):2467-72. PubMed ID: 14581399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autoantibodies against oxidatively modified LDL do not constitute a risk factor for stroke: a nested case-control study.
    Ahmed E; Trifunovic J; Stegmayr B; Hallmans G; Lefvert AK
    Stroke; 1999 Dec; 30(12):2541-6. PubMed ID: 10582975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2.
    Lourida ES; Georgiadis AN; Papavasiliou EC; Papathanasiou AI; Drosos AA; Tselepis AD
    Arthritis Res Ther; 2007; 9(1):R19. PubMed ID: 17326817
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease.
    Ogasawara K; Mashiba S; Wada Y; Sahara M; Uchida K; Aizawa T; Kodama T
    Atherosclerosis; 2004 Jun; 174(2):349-56. PubMed ID: 15136066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction.
    Sjögren P; Fredrikson GN; Samnegard A; Ericsson CG; Ohrvik J; Fisher RM; Nilsson J; Hamsten A
    Eur Heart J; 2008 Sep; 29(18):2218-26. PubMed ID: 18664466
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autoantibodies against malondialdehyde-modified LDL are elevated in subjects with an LDL subclass pattern B.
    Jansen H; Ghanem H; Kuypers JH; Birkenhäger JC
    Atherosclerosis; 1995 Jun; 115(2):255-62. PubMed ID: 7661884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Malondialdehyde-Modified LDL IgG Antibody Levels and Indices of Cardiac Function in Valvular Heart and Coronary Artery Disease Patients.
    Rahsepar AA; Mirzaee A; Moodi F; Moohebati M; Tavallaie S; Khorashadizadeh F; Mottahedi B; Esfehanizadeh J; Azari A; Khojasteh R; Mousavi S; Paydar R; Amini M; Ghayour-Mobarhan M; Ferns GA; Sahebkar A
    Med Princ Pract; 2015; 24(5):424-31. PubMed ID: 26139161
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The autoantibody repertoire against copper- or macrophage-modified LDL differs in normolipidemics and hypercholesterolemic patients.
    Fernvik EC; Ketelhuth DF; Russo M; Gidlund M
    J Clin Immunol; 2004 Mar; 24(2):170-6. PubMed ID: 15024184
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoantibodies to oxidized low-density lipoprotein in patients with type 2 diabetes mellitus.
    Hsu RM; Devaraj S; Jialal I
    Clin Chim Acta; 2002 Mar; 317(1-2):145-50. PubMed ID: 11814469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Measurement peripheral blood index related to inflammation and ox-LDL, ox-LDLAb in patients with coronary heart disease and its clinical significance].
    Zhou ZX; Qiang H; Ma AQ; Chen H; Zhou P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):258-62. PubMed ID: 16706128
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The level of malondialdehyde-modified LDL and LDL immune complexes in patients with rheumatoid arthritis.
    Wang J; Hu B; Meng Y; Zhang C; Li K; Hui C
    Clin Biochem; 2009 Sep; 42(13-14):1352-7. PubMed ID: 19501077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction.
    Tornvall P; Båvenholm P; Landou C; de Faire U; Hamsten A
    Circulation; 1993 Nov; 88(5 Pt 1):2180-9. PubMed ID: 8222113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating malondialdehyde-modified low-density lipoprotein levels are associated with the presence of thin-cap fibroatheromas determined by optical coherence tomography in coronary artery disease.
    Matsuo Y; Kubo T; Okumoto Y; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Kitabata H; Hirata K; Imanishi T; Akagi H; Akasaka T
    Eur Heart J Cardiovasc Imaging; 2013 Jan; 14(1):43-50. PubMed ID: 22573905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes of autoantibodies against oxidatively modified low density lipoproteins during long-term LDL-apheresis.
    Turk Z; Mrzljak V; Turk N; Metelko Z
    Diabetes Nutr Metab; 1999 Dec; 12(6):413-7. PubMed ID: 10782563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction.
    Hamsten A; Walldius G; Szamosi A; Dahlen G; de Faire U
    Circulation; 1986 Jun; 73(6):1097-110. PubMed ID: 3698244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma levels of oxidized-low-density lipoproteins are higher in patients with unstable angina and correlated with angiographic coronary complex plaques.
    Anselmi M; Garbin U; Agostoni P; Fusaro M; Pasini AF; Nava C; Keta D; Turri M; Zardini P; Vassanelli C; Lo Cascio V; Cominacini L
    Atherosclerosis; 2006 Mar; 185(1):114-20. PubMed ID: 15998517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3).
    van den Berg VJ; Haskard DO; Fedorowski A; Hartley A; Kardys I; Caga-Anan M; Akkerhuis KM; Oemrawsingh RM; van Geuns RJ; de Jaegere P; van Mieghem N; Regar E; Ligthart JMR; Umans VAWM; Serruys PW; Melander O; Boersma E; Khamis RY
    EBioMedicine; 2018 Oct; 36():63-72. PubMed ID: 30131305
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
    Bakalova RA; Hadzhimitova V; Ribarov S
    Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of vitamin E supplementation on antibody levels against malondialdehyde modified LDL in hyperlipidemic hamsters.
    de Oliveira FG; Rossi CL; de Oliveira MG; Saad MJ; Velloso LA
    Cardiovasc Res; 2000 Aug; 47(3):567-73. PubMed ID: 10963729
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High plasma immunoglobulin (Ig) A and low IgG antibody titers to oxidized low-density lipoprotein are associated with markers of glucose metabolism.
    Sämpi M; Veneskoski M; Ukkola O; Kesäniemi YA; Hörkkö S
    J Clin Endocrinol Metab; 2010 May; 95(5):2467-75. PubMed ID: 20332251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.